Date: 11th May 2011
May 11th 2011 - ELC GROUP,the pan-European pharmaceutical regulatory affairs organisation, today announced that former President of The Organisation for Professionals in Regulatory Affairs (TOPRA), Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA has joined the ELC GROUP Advisory Board.
Dr. Biffignandi is a world-renowned physician, with PhDs in endocrinology and pharmacology. He is a Fellow of TOPRA, as well as an Overseas Fellow of the Royal Society of Medicine (UK).
Dr. Biffignandi brings over 30 years' experience in Regulatory Affairs and pharmacovigilance to the company's Advisory Board.
Speaking about the appointment ELC GROUP CEO Marco Rubinstein said: “We are honoured to have Dr Biffignandi join us and his exceptional experience and success throughout his career brings a unique perspective to our advisory board.”
ELC’s Business Development Manager Akhil Jain said: "We are pleased to welcome Paolo to ELC's Advisory Board and look forward to his industry insight and contributions to ELC's strategic plans. ELC has had the privilege to work with Dr. Biffignandi. His experience in the Regulatory Affairs space is immeasurable and his industry contributions are well noted. He is a very experienced addition to our team."
Commenting on his appointment Dr Biffignandi said: “ELC GROUP is the industry expert, and I'm pleased to accept this opportunity to join its Advisory Board and to contribute to its continued strategic success. I look forward to contributing to the company's vision and sharing my experience in Regulatory Affairs."
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00
Miranda [at] evokedset [dot] com
Phone: +44 (0)7957 391 498
About ELC Group
ELC GROUP is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries as well as REACH services to the Chemical industry. It helps companies that lack the resource (skills and knowledge) to cost effectively deliver regulatory affairs.
ELC Group provides full-service, multi-lingual consulting and cost-effective solutions to regulatory approvals using experts with in-depth knowledge and experience throughout the world. The team ranges from former FDA investigators to individuals with over 30 years of industry experience with broad capabilities. This includes integrated advanced technologies, regulatory affairs consulting and commercialisation services.